These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. ECT, opioid system, and motor response in Parkinson's disease . Sandyk R Biol Psychiatry; 1986 Feb; 21(2):235-6. PubMed ID: 3004611 [No Abstract] [Full Text] [Related]
23. Catatonic stupor during the course of Parkinson's disease resolved with electroconvulsive therapy. Suzuki K; Awata S; Nakagawa K; Takano T; Matsuoka H Mov Disord; 2006 Jan; 21(1):123-4. PubMed ID: 16250024 [No Abstract] [Full Text] [Related]
24. [Present status of non-drug therapy and transcranial magnetic stimulation therapy for patients with Parkinson's disease]. Akamatsu N; Tsuji S Nihon Naika Gakkai Zasshi; 2003 Aug; 92(8):1456-60. PubMed ID: 13677894 [No Abstract] [Full Text] [Related]
25. ECT for Parkinson's? Martin BA CMAJ; 2003 May; 168(11):1391-2; author reply 1392. PubMed ID: 12771059 [No Abstract] [Full Text] [Related]
26. Temporary interruption of deep brain stimulation for Parkinson's disease during outpatient electroconvulsive therapy for major depression: a novel treatment strategy. Ducharme S; Flaherty AW; Seiner SJ; Dougherty DD; Morales OG J Neuropsychiatry Clin Neurosci; 2011; 23(2):194-7. PubMed ID: 21677249 [TBL] [Abstract][Full Text] [Related]
27. [Electroconvulsive therapy in Parkinson disease. Description of three cases]. Avila A; Sastre F; Cardona X; Maho P; Bello J; Sancho I Neurologia; 1997; 12(7):313-6. PubMed ID: 9432202 [TBL] [Abstract][Full Text] [Related]
38. Parkinson's disease, depression, and ECT: a review and case study. Asnis G Am J Psychiatry; 1977 Feb; 134(2):191-5. PubMed ID: 835744 [TBL] [Abstract][Full Text] [Related]
39. [Electroconvulsive therapy for neurological disorders]. Doi N; Sameshima T; Suwa H; Mera H; Nagao T; Yokochi M; Nakamura M; Isse K Brain Nerve; 2007 Apr; 59(4):313-20. PubMed ID: 17447517 [TBL] [Abstract][Full Text] [Related]
40. Use of electroconvulsive therapy in Parkinson disease with residual axial symptoms partially unresponsive to L-dopa: a pilot study. Pintor LP; Valldeoriola F; Fernández-Egea E; Sánchez R; Rami L; Tolosa E; Muñiz A; Martí MJ; Bernardo M J ECT; 2012 Jun; 28(2):87-91. PubMed ID: 22531200 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]